Budget vs premium
Embody vs TMates: Which Costs Less Over 12 Months? (2026)
Compare Embody and TMates on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.6 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Both Embody and TMates will get a GLP-1 prescription to your door without an in-person visit. The question is what the year after that first shipment looks like.
TMates costs 2.9x more per month than Embody once promotional pricing is out of the picture ($199/mo against $69/mo). Over a year that gap compounds into real money, and the question is what it buys.
What follows is a like-for-like read of both programs: entry pricing, maintenance pricing, formulary, support model and the terms attached to each. No number here is inferred; if a provider does not publish it, the table says so.
The short answer
- Lowest 12-month cost
- Embody — $828 against $2,388 at TMates, on each provider's own best published pricing.
- Most predictable bill
- TMates — Flat rate at every dose, so titration does not change what you are charged.
- Tirzepatide access
- Embody — Tirzepatide at $119/mo; the other side publishes semaglutide only.
- Most support included
- TMates — 24/7 access to U.S.-based doctors, not just messaging.
Embody and TMates, side by side
Every figure below is the provider's own published number. The blank spaces are theirs, not ours.
| Embody | TMates | |
|---|---|---|
| Advertised price | Semaglutide $69/mo (was $299), tirzepatide $119/mo | $199/mo at every dose, no step-up fees |
| Rate after promotions | $69/mo | $199/mo |
| Pricing structure | Published rate per medication | Flat rate at every dose |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide |
| State coverage | Not published | All 50 states |
| How fast you start | Licensed provider review handled entirely online | Virtual check-in appointments |
| Membership fee | None | None |
| Payment options | Card only, no financing published | Card only, no financing published |
| Patient reviews | 11,250 | 21,970 |
| eRxDoctor score | 7.6/10 | 7.0/10 |
Cost over a full course of treatment
Trial data runs to 68 and 72 weeks; the pricing people compare runs to 30 days. What matters is the total at the point most people are still in treatment, so both programs are extended to six and twelve months below.
| Embody | TMates | |
|---|---|---|
| First month | $69 | $199 |
| Months 2 onward | $69/mo | $199/mo |
| 6-month total | $414 | $1,194 |
| 12-month total | $828 | $2,388 |
| Best published plan | No multi-month discount published | No multi-month discount published |
The twelve-month spread is $1,560. That is the number to hold TMates against: it has to justify roughly $130 extra every month.
What the price difference actually buys
TMates charges $199/mo where Embody charges $69/mo. A premium is defensible only if it maps to something specific, so here is what TMates puts behind it: 24/7 access to U.S.-based doctors, not just messaging, and medication formulated in U.S. facilities.
Embody counters with the lowest published semaglutide price on this list, with no lock-in, and the thing it asks you to accept in return: a limited-time rate with few of the extras that higher-priced platforms bundle.
Price gaps in this market rarely reflect a different molecule; they reflect a different amount of human contact. Decide how much of that you actually intend to use before paying for it.
A closer look at Embody
Semaglutide $69/mo (was $299), Tirzepatide $119/mo Against TMates, that puts it in the position of the cheaper option.
From signup to first shipment: licensed provider review handled entirely online, then free shipping, 1-2 day delivery after approval. Billing follows a published rate per medication structure.
Behind the prescription sits 24/7 support for dosing and side-effect questions. Available medication: compounded semaglutide and compounded tirzepatide.
Embody pros
- Compounded tirzepatide available at $119/month
- Lowest entry price on this list at $69/month for compounded semaglutide
- No long-term commitment; cancel without penalty
- Free shipping with fast 1–2 day delivery after approval
Embody cons
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Fewer premium features (no integrated coaching or advanced monitoring) than higher-priced platforms
- Final pricing may vary based on dose and clinician recommendation
Read next to TMates, the weak point: a limited-time rate with few of the extras that higher-priced platforms bundle.
TMates: what you are buying
$199/month, every dose, no step-up fees What it is really selling here is one flat $199 that survives every titration step, with doctors rather than a message queue behind it.
You start with virtual check-in appointments; medication arrives via medication formulated in U.S. facilities. The price behaves as flat rate at every dose.
On the clinical side, 24/7 access to U.S.-based doctors, not just messaging, prescribing compounded semaglutide.
TMates pros
- Virtual check-in appointments for ongoing medical oversight
- Flat $199/month at every dose, no step-up fees as dosage escalates
- 24/7 access to U.S.-based doctors, not just messaging support
- Licensed coverage in all 50 states
TMates cons
- Compounded semaglutide only, limited public detail on tirzepatide availability
- $199/month is higher than the cheapest compounded options
- No branded Ozempic, Wegovy, or Zepbound
The reservation worth holding, particularly next to Embody: semaglutide only, and $199 is well above the cheapest compounded options.
Picking between them
Choose Embody if:
- you want to start on their timeline: licensed provider review handled entirely online
- the level of clinical contact suits you: 24/7 support for dosing and side-effect questions
- delivery works the way you want it to: free shipping, 1-2 day delivery after approval
- you want tirzepatide available without changing provider later
Choose TMates if:
- delivery works the way you want it to: medication formulated in U.S. facilities
- you want to start on their timeline: virtual check-in appointments
- you are in a state where GLP-1 telehealth coverage is patchy
- you want the price you sign up at to survive titration
The trade-offs, stated plainly
On price. The monthly gap is 2.9x in Embody's favor. Whether that is a saving or a false economy turns on one thing: a limited-time rate with few of the extras that higher-priced platforms bundle.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On predictability. The pricing structures differ (published rate per medication versus flat rate at every dose), and structure, not headline rate, determines the twelve-month bill.
On access. Embody advertises licensed provider review handled entirely online and free shipping, 1-2 day delivery after approval; TMates advertises virtual check-in appointments and medication formulated in U.S. facilities. Coverage differs too — not published against all 50 states — which decides the question before price does if you are in a restricted state.
The clinical evidence, separated from the marketing
The efficacy data people cite when comparing these platforms is not platform data. It comes from trials of the underlying medication, and it applies to both.
NIDDK frames medication as one component of obesity treatment rather than a replacement for the rest of it, per NIH, NIDDK.
The FDA approved tirzepatide for chronic weight management in November 2023, two years after semaglutide, per FDA.
Which is to say: the medication decision belongs with a clinician, and the platform decision belongs with a spreadsheet.
Embody vs TMates: common questions
What happens when Embody's promotional price ends?
The rate moves to $69/mo, a 0% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Which costs less over a year, Embody or TMates?
Embody, at roughly $828 for twelve months against $2,388 at TMates, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Is Embody cheaper than TMates?
Yes, on the ongoing rate. Embody runs $69/mo once promotional pricing ends, against $199/mo at TMates — a difference of 2.9x. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Do Embody or TMates take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Which has more patient reviews, Embody or TMates?
TMates, with 21,970 against 11,250. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Does Embody or TMates offer tirzepatide?
Embody does, at $119/mo. TMates publishes compounded semaglutide only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
The verdict
On the numbers, Embody wins the year: $828 against $2,388. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
Where TMates justifies itself is one flat $199 that survives every titration step, with doctors rather than a message queue behind it. Where it does not is anywhere the extra spend buys features you will never open.
Whichever you choose, diarise the month the introductory pricing ends and re-run the comparison then. Neither platform will remind you.
Keep comparing
- Embody vs He & She MDBudget vs premium
- Embody vs MaximusBudget vs premium
- Elevate Health vs TMatesTirzepatide access
- Mochi Health vs TMatesBudget vs premium
- Yucca Health vs JoinFridaysBudget vs premium
- Yucca Health vs MedViBudget vs premium
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Embody or TMates, and does not sell treatment. Read our ranking methodology.